Alkem Laboratories (NSE:ALKEM) Interest Expense : ₹-1,009 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Alkem Laboratories's interest expense for the three months ended in Dec. 2023 was ₹ -255 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-1,009 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Alkem Laboratories's Operating Income for the three months ended in Dec. 2023 was ₹ 6,379 Mil. Alkem Laboratories's Interest Expense for the three months ended in Dec. 2023 was ₹ -255 Mil. Alkem Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 was 25.06. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alkem Laboratories Interest Expense Historical Data

The historical data trend for Alkem Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories Interest Expense Chart

Alkem Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Expense

Get a 7-Day Free Trial

-497.80

-542.60

-488.50

-408.40

-937.50

Alkem Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-270.50	-153.50	-297.70	-303.20	-254.60

Alkem Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1,009 Mil.

Alkem Laboratories (NSE:ALKEM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alkem Laboratories's Interest Expense for the three months ended in Dec. 2023 was ₹-255 Mil. Its Operating Income for the three months ended in Dec. 2023 was ₹6,379 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was ₹0 Mil.

Alkem Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	6379.3	/	-254.6
	=	25.06

The higher the ratio, the stronger the company's financial strength is.

Alkem Laboratories (NSE:ALKEM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » Interest Expense

Traded in Other Exchanges

539523:India

Address

Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.alkemlabs.com

Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines